» Articles » PMID: 25038937

Molecular Determinants of Influenza Virus Pathogenesis in Mice

Overview
Date 2014 Jul 21
PMID 25038937
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Mice are widely used for studying influenza virus pathogenesis and immunology because of their low cost, the wide availability of mouse-specific reagents, and the large number of mouse strains available, including knockout and transgenic strains. However, mice do not fully recapitulate the signs of influenza infection of humans: transmission of influenza between mice is much less efficient than in humans, and influenza viruses often require adaptation before they are able to efficiently replicate in mice. In the process of mouse adaptation, influenza viruses acquire mutations that enhance their ability to attach to mouse cells, replicate within the cells, and suppress immunity, among other functions. Many such mouse-adaptive mutations have been identified, covering all 8 genomic segments of the virus. Identification and analysis of these mutations have provided insight into the molecular determinants of influenza virulence and pathogenesis, not only in mice but also in humans and other species. In particular, several mouse-adaptive mutations of avian influenza viruses have proved to be general mammalian-adaptive changes that are potential markers of pre-pandemic viruses. As well as evaluating influenza pathogenesis, mice have also been used as models for evaluation of novel vaccines and anti-viral therapies. Mice can be a useful animal model for studying influenza biology as long as differences between human and mice infections are taken into account.

Citing Articles

Influenza virus evolution and defective genome formation are shaped by host genotype and sex.

Costa R, Acosta-Alvarez L, Curtis K, Zarbock K, Kelleher J, Lamichhane B bioRxiv. 2025; .

PMID: 40060519 PMC: 11888471. DOI: 10.1101/2025.02.26.638946.


Innate immune control of influenza virus interspecies adaptation via IFITM3.

Denz P, Speaks S, Kenney A, Eddy A, Papa J, Roettger J Nat Commun. 2024; 15(1):9375.

PMID: 39477971 PMC: 11525587. DOI: 10.1038/s41467-024-53792-3.


Two amino acid residues in the N-terminal region of the polymerase acidic protein determine the virulence of Eurasian avian-like H1N1 swine influenza viruses in mice.

Yang Y, Xu C, Zhang N, Wan Y, Wu Y, Meng F J Virol. 2024; 98(10):e0129324.

PMID: 39212447 PMC: 11495010. DOI: 10.1128/jvi.01293-24.


STING Agonist Induced Innate Immune Responses Drive Anti-Respiratory Virus Activity with Limited Antiviral Efficacy .

Broeckel R, Browne A, Sucoloski S, Cantizani J, Simpson J, Pesiridis S ACS Infect Dis. 2024; 10(9):3392-3407.

PMID: 39207884 PMC: 11406527. DOI: 10.1021/acsinfecdis.4c00504.


mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020.

Allen J, Ross T Front Immunol. 2024; 15:1334670.

PMID: 38533508 PMC: 10963417. DOI: 10.3389/fimmu.2024.1334670.


References
1.
van der Laan J, Herberts C, Lambkin-Williams R, Boyers A, Mann A, Oxford J . Animal models in influenza vaccine testing. Expert Rev Vaccines. 2008; 7(6):783-93. DOI: 10.1586/14760584.7.6.783. View

2.
Castrucci M, Kawaoka Y . Biologic importance of neuraminidase stalk length in influenza A virus. J Virol. 1993; 67(2):759-64. PMC: 237428. DOI: 10.1128/JVI.67.2.759-764.1993. View

3.
Sun X, Jayaraman A, Maniprasad P, Raman R, Houser K, Pappas C . N-linked glycosylation of the hemagglutinin protein influences virulence and antigenicity of the 1918 pandemic and seasonal H1N1 influenza A viruses. J Virol. 2013; 87(15):8756-66. PMC: 3719814. DOI: 10.1128/JVI.00593-13. View

4.
Vigerust D, Ulett K, Boyd K, Madsen J, Hawgood S, McCullers J . N-linked glycosylation attenuates H3N2 influenza viruses. J Virol. 2007; 81(16):8593-600. PMC: 1951338. DOI: 10.1128/JVI.00769-07. View

5.
Tripp R, Tompkins S . Animal models for evaluation of influenza vaccines. Curr Top Microbiol Immunol. 2009; 333:397-412. DOI: 10.1007/978-3-540-92165-3_19. View